Impact of Haemodialysis: Analysis of Haemoglobin Levels and Blood Pressure Control in Patients with End-Stage Renal Disease
DOI:
https://doi.org/10.33755/jkk.v10i5.755Keywords:
Blood pressure, End Stage Renal Disease (ESRD), Hemodialysis, Hemoglobin, PatientsAbstract
Aims: To analyze the effect of hemodialysis on hemoglobin levels and blood pressure in patients with End Stage Renal Disease (ESRD).
Method: The study used a one-group pretest-posttest design with 17 respondents. Data were collected using EDTA tubes, sphygmomanometers, and stethoscopes. A paired t-test and Wilcoxon signed-rank test were applied to analyze the significance of changes between pretest and posttest results
Results: The mean hemoglobin level before hemodialysis was 7.92 g/dL and increased to 8.50 g/dL after hemodialysis (p = 0.001). The mean systolic blood pressure decreased from 136.6 mmHg before to 124.0 mmHg after hemodialysis (p = 0.003). However, there was no significant difference in diastolic blood pressure, with an average of 80.6 mmHg before and 78.6 mmHg after hemodialysis (p = 0.180).
Conclusion: It can be concluded that hemodialysis significantly increases hemoglobin levels and reduces systolic blood pressure in ESRD patients, while diastolic blood pressure remains unchanged. Regular monitoring of hemoglobin and systolic blood pressure is crucial for managing patient health. Hemodialysis effectively raises hemoglobin levels and reduces systolic blood pressure in ESRD patients. Regular monitoring of both parameters is essential for effective patient management. While the findings highlight the benefits of hemodialysis, the limited sample size may restrict the generalizability of the results. Further studies with larger sample sizes are needed to confirm these findings and explore the long-term implications.
References
Institute for Health Metric and Evaluation (IHME). Global Burden of Disease 2021: Findings from the GBD 2021 Study. Seattle; 2024.
Perhimpunan Nefrologi Indonesia. 13th ANNUAL REPORT OF INDONESIAN RENAL REGISTRY 2020 [Internet]. 2023 Oct. Available from: www.indonesianrenalregistry.org
National Kidney Foundation. Choosing a Treatment for Kidney Failure. New york; 2022. 1–35 p.
Bansal N, Artinian NT, Bakris G, Chang T, Cohen J, Flythe J, et al. Hypertension in Patients Treated with In-Center Maintenance Hemodialysis: Current Evidence and Future Opportunities: A Scientific Statement from the American Heart Association. Vol. 80, Hypertension. Lippincott Williams and Wilkins; 2023. p. E112–22. doi: 10.1161/HYP.0000000000000230.
Lewandowski MJ, Krenn S, Kurnikowski A, Bretschneider P, Sattler M, Schwaiger E, et al. Chronic kidney disease is more prevalent among women but more men than women are under nephrological care: Analysis from six outpatient clinics in Austria 2019. Wien Klin Wochenschr. 2023 Feb 1;135(3–4):89–96. doi: 10.1007/s00508-022-02074-3
Kohagura K. The public health impact of hypertension and diabetes: a powerful tag team for the development of chronic kidney disease. Vol. 46, Hypertension Research. Springer Nature; 2023. p. 339–40. doi: 10.1038/s41440-022-01114-9
Kooman JP, van der Sande FM, Leunissen KML. Kidney disease and aging: A reciprocal relation. Exp Gerontol. 2017 Jan 1;87:156–9. doi: 10.1016/j.exger.2016.02.003.
Syahputra A, Abdurrahman A, Mutiah C. Perbandingan Kadar Hemoglobin Sebelum Dan Sesudah Hemodialisa Pada Pasien Gagal Ginjal Kronis. Malahayati Nursing Journal. 2022 Jul 1;4(7):1749–56. DOI: https://doi.org/10.33024/mnj.v4i7.6546
Fishbane S, Spinowitz B. Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018. American Journal of Kidney Diseases. 2018 Mar 1;71(3):423–35. doi: 10.1053/j.ajkd.2017.09.026.
Jundiah S, Muliani R, Alawiyah E. RELATIONSHIP BETWEEN ANEMIA AND THE QUALITY OF LIFE OF CLIENTS OF CHRONIC KIDNEY DISEASE UNDERGOING HEMODIALYSIS. In 2019.
PERNEFRI. KONSENSUS MANAJEMEN ANEMIA PADA PENYAKIT GINJAL KRONIK. Jakarta: Perhimpunan Nefrologi Indonesia; 2011.
Sagheb MM, Fallahzadeh MA, Moaref A, Fallahzadeh MH, Dormanesh B. Comparison of hemoglobin levels before and after hemodialysis and their effects on erythropoietin dosing and cost. Nephrourol Mon. 2016 Jul 1;8(4). doi: 10.5812/numonthly.38495
Canaud B, Chazot C, Koomans J, Collins A. Fluid and hemodynamic management in hemodialysis patients: challenges and opportunities. Brazilian Journal of Nephrology. 2019;41:550–9. doi: 10.1590/2175-8239-JBN-2019-0135.
Chou JA, Kalantar-Zadeh K. Volume balance and intradialytic ultrafiltration rate in the hemodialysis patient. Curr Heart Fail Rep. 2017;14:421–7. doi: 10.1007/s11897-017-0356-6.
Mallamaci F, Torino C, Sarafidis P, Ekart R, Loutradis C, Siamopoulos K, et al. Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study. In: Journal of Hypertension. Lippincott Williams and Wilkins; 2020. p. 1849–56. doi: 10.1097/HJH.0000000000002448.
Dhondup T, Qian Q. Electrolyte and Acid-Base Disorders in Chronic Kidney Disease and End-Stage Kidney Failure. Vol. 43, Blood Purification. S. Karger AG; 2017. p. 179–88. doi: 10.1159/000452725
Biggar P, Kim GH. Treatment of renal anemia: Erythropoiesis stimulating agents and beyond. Kidney Res Clin Pract. 2017;36(3):209. doi: 10.23876/j.krcp.2017.36.3.209.
Vega A, Abad S, Verdalles U, Aragoncillo I, Velazquez K, Quiroga B, et al. Dose equivalence between continuous erythropoietin receptor activator (CERA), Darbepoetin and Epoetin in patients with advanced chronic kidney disease. Hippokratia. 2014;18(4):315.
Paranoan R, AManggau M, Kasim H, Natsir Djide M, Lallo S, Yusrini Djabir Y, et al. ANALISIS EFEKTIVITAS DAN EFEK SAMPING PENGGUNAAN ANTIHIPERTENSI PADA PASIEN GAGAL GINJAL KRONIK RAWAT INAP DI RSUP Dr. WAHIDIN SUDIROHUSODO. Majalah Farmasi dan Farmakologi [Internet]. 2019;23(1):13–5. Available from: http://journal.unhas.ac.id. DOI:10.20956/mff.v23i1.6460
Georgianos PI, Agarwal R. Systolic and diastolic hypertension among patients on hemodialysis: Musings on volume overload, arterial stiffness, and erythropoietin. Vol. 32, Seminars in Dialysis. Blackwell Publishing Inc.; 2019. p. 507–12. doi: 10.1111/sdi.12837. Epub 2019 Aug 28.
